Suspicion d’allergie à une bêta-lactamine chez l’enfant

Autor: Dufrois, C., Lezmi, G., Ponvert, C., Caubet, J.-C., Benoist, G.

Publikováno v: In Perfectionnement en Pédiatrie March 2023 6(1):16-22

Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper.

Autor: Mayorga, C., Çelik, G. E., Pascal, M., Hoffmann, H. J., Eberlein, B., Torres, M. J., Brockow, K., Garvey, L. H., Barbaud, A., Madrigal‐Burgaleta, R., Caubet, J. C., Ebo, D. G.

Publikováno v: Allergy; Mar2024, Vol. 79 Issue 3, p580-600, 21p

COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations

Autor: Jutel M., Torres M.J., Palomares O., Akdis C.A., Eiwegger T., Untersmayr E., Barber D., Zemelka-Wiacek M., Kosowska A., Palmer E., Vieths S., Mahler V., Canonica W.G., Nadeau K., Shamji M.H., Agache I., Akdis M., Khaitov M., Alvarez-Perea A., Alvaro-Lozano M., Atanaskovic-Markovic M., Backer V., Barbaud A., Bavbek S., de Blay F., Bonini M., Bonini S., van Boven J.F.M., Brockow K., Cazzola M., Chatzipetrou A., Chivato T., Cianferoni A., Corren J., Cristoph-Caubet J., Dunn-Galvin A., Ebisawa M., Firinu D., Gawlik R., Gelincik A., del Giacco S., Mortz C.G., Jurgen Hoffmann H., Hoffmann-Sommergruber K., Klimek L., Knol E., Lauerma A., de Llano L.P., Matucci A., Meyer R., Moreira A., Morita H., Patil S.U., Pfaar O., Popescu F.-D., del Pozo V., Price O.J., van Ree R., Fernandez-Rivas M., Rogala B., Romano A., Santos A., Sediva A., Skypala I., Smolinska S., Sokolowska M., Sturm G., Vultaggio A., Walusiak-Skorupa J., Worm M.

Publikováno v: Hoffmann, H J & Hans Jürgen Hoffmann 2022, ' COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations ', Allergy . https://doi.org/10.1111/all.15252
Allergy (Cph.) (2022). doi:10.1111/all.15252
info:cnr-pdr/source/autori:Jutel M.; Torres M.J.; Palomares O.; Akdis C.A.; Eiwegger T.; Untersmayr E.; Barber D.; Zemelka-Wiacek M.; Kosowska A.; Palmer E.; Vieths S.; Mahler V.; Canonica W.G.; Nadeau K.; Shamji M.H.; Agache I.; Akdis M.; Khaitov M.; Alvarez-Perea A.; Alvaro-Lozano M.; Atanaskovic-Markovic M.; Backer V.; Barbaud A.; Bavbek S.; de Blay F.; Bonini M.; Bonini S.; van Boven J.F.M.; Brockow K.; Cazzola M.; Chatzipetrou A.; Chivato T.; Cianferoni A.; Corren J.; Cristoph-Caubet J.; Dunn-Galvin A.; Ebisawa M.; Firinu D.; Gawlik R.; Gelincik A.; del Giacco S.; Mortz C.G.; Jurgen Hoffmann H.; Hoffmann-Sommergruber K.; Klimek L.; Knol E.; Lauerma A.; de Llano L.P.; Matucci A.; Meyer R.; Moreira A.; Morita H.; Patil S.U.; Pfaar O.; Popescu F.-D.; del Pozo V.; Price O.J.; van Ree R.; Fernandez-Rivas M.; Rogala B.; Romano A.; Santos A.; Sediva A.; Skypala I.; Smolinska S.; Sokolowska M.; Sturm G.; Vultaggio A.; Walusiak-Skorupa J.; Worm M./titolo:COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals--EAACI recommendations/doi:10.1111%2Fall.15252/rivista:Allergy (Cph.)/anno:2022/pagina_da:/pagina_a:/intervallo_pagine:/volume
Allergy: European Journal of Allergy and Clinical Immunology, 77(8), 2313-2336. Wiley-Blackwell
Allergy, 77(8), 2313-2336. Wiley-Blackwell
ALLERGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

Immune modulation is a key therapeutic approach for allergic diseases, asthma and autoimmunity. It can be achieved in an antigen-specific manner via allergen immunotherapy (AIT) or in an endotype-driven approach using biologicals that target the majo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d83ae1885fca06c28118da1a2ac94eb7
http://www.scopus.com/inward/record.url?scp=85126729643&partnerID=8YFLogxK

Mécanismes de l’œsophagite à éosinophile et implications thérapeutiques

Autor: Caubet, J.-C.

Publikováno v: In Revue Française d'Allergologie April 2019 59(3):235-236

COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations

Autor: Jutel, M. Torres, M.J. Palomares, O. Akdis, C.A. Eiwegger, T. Untersmayr, E. Barber, D. Zemelka-Wiacek, M. Kosowska, A. Palmer, E. Vieths, S. Mahler, V. Canonica, W.G. Nadeau, K. Shamji, M.H. Agache, I. Akdis, M. Khaitov, M. Alvarez-Perea, A. Alvaro-Lozano, M. Atanaskovic-Markovic, M. Backer, V. Barbaud, A. Bavbek, S. de Blay, F. Bonini, M. Bonini, S. van Boven, J.F.M. Brockow, K. Cazzola, M. Chatzipetrou, A. Chivato, T. Cianferoni, A. Corren, J. Cristoph-Caubet, J. Dunn-Galvin, A. Ebisawa, M. Firinu, D. Gawlik, R. Gelincik, A. del Giacco, S. Mortz, C.G. Jürgen Hoffmann, H. Hoffmann-Sommergruber, K. Klimek, L. Knol, E. Lauerma, A. de Llano, L.P. Matucci, A. Meyer, R. Moreira, A. Morita, H. Patil, S.U. Pfaar, O. Popescu, F.-D. del Pozo, V. Price, O.J. van Ree, R. Fernández-Rivas, M. Rogala, B. Romano, A. Santos, A. Sediva, A. Skypala, I. Smolinska, S. Sokolowska, M. Sturm, G. Vultaggio, A. Walusiak-Skorupa, J. Worm, M.

Immune modulation is a key therapeutic approach for allergic diseases, asthma and autoimmunity. It can be achieved in an antigen-specific manner via allergen immunotherapy (AIT) or in an endotype-driven approach using biologicals that target the majo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::9cb3f9f8cbe04e2929d0b09002b87112
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220155